The appointment enables the institutions to offer high-value-added services that were previously provided by EATRIS Coordination and Support. The services include regulatory support, innovation management, and translational feasibility support, and complement existing laboratory research services.
EATRIS Appoints IDIBELL as an Expert Centre Read More »
A study by the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) with the Arctic University of Norway compares the effect of two treatments on the alterations in mitochondrial respiration in obesity.
GLP-1 Receptor Agonist Improves Mitochondrial Function in Obese Mice Read More »
A study published in the journal Science Advances reveals that 9-month-old babies are sensitive to non-adjacent grammatical regularities contained in language components
Speech rhythm and pitch are fundamental in babies’ language acquisition Read More »
Now a work co-led by the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) together with the LMU in Munich has studied the antitumor effect of an enzyme elimination in viruses of the poxvirus family
A group from IDIBELL, the Catalan Institute of Oncology and CIBERONC has identified new genes predisposing to different types of polyposis which, if confirmed, could determine the clinical management of carriers.
Researchers identify new genes predisposing to colorectal polyposis Read More »
The Agency for the Management of University and Research Grants (AGAUR) has published this week the final resolution of the call for grants to support the activities of research groups from universities, centers and foundations. In this year’s call, 32 IDIBELL groups have been recognized as Consolidated or Emerging Research Groups, of which 19 will receive funding.
The Generalitat recognizes 32 IDIBELL groups as Consolidated or Emerging Research Groups Read More »
The research group on Cognition and Brain Plasticity from IDIBELL and the UB answered this question with an experiment in the Milan auditorium, with the Milan orchestra and 1,000 members of the public as study participants.
Curiosity or pleasure, what comes first when we listen to a song? Read More »
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL), the Sant Joan de Déu Research Institute (IRSJD), Sant Pau Research Institute (IIB Sant Pau) and the UB generated the first model of this disease that reproduce patients’ characteristics and response to treatment.
DEGS1 also appears as a main actor of mitochondrial function, which may have implications for the management of diseases caused by lipid imbalance.
This is a proposal coordinated by IDIBELL and financed by AGAUR in which 13 other institutions participate. XarSMART will offer projects access to experts in regulatory, eHealth, data science and precision medicine.
